Retatrutide for Hashimoto's (what you need to know)
Dr. Jones, DC — Retatrutide for Hashimoto's (what you need to know)
Channel: Dr. Jones, DC · Our label: Chiropractor / clinician creator · Source: youtube.com/watch?v=YnfyTjU4DGQ
What this video covers
If you’ve been on level thyroxine for years, stable, dialed in, no issues, and then you started read a true tide and now your thyroid labs are coming back different, your prescriber may not have flagged it as related. And maybe you believe them for a while, but you’re here, which means the labs didn’t go back to normal on their own. You see, we’re starting to see this regularly in our practice as more people come in already on reachide. Hashimoto is a autoimmune condition that affects the thyroid and produces hypothyroid in many patients.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- Jones DC and I lead a nationwide GLP-1 and metabolic clinic.
- Her prescriber looks at it and says, “hm, let’s wait and see.” No adjustment, no explanation, no additional testing ordered.
- Free T3, free T4, TBO antibodies, the thyroid globulin antibodies, inflammatory markers, reverse T3, when the clinical picture warrants it.
- Inflammation, the vicious cycle where inflammation creates more dysfunction which creates more inflammation.
- Though thyroid specific data are still building BPC57 and KPV in experimental models both show effects on gut mucosal repair and inflammatory signaling.
- And then reachide itself, not just as a weight loss tool, but as a compound that by driving substantial fat loss, can reduce the atapost driven inflammatory signaling that’s been stoking the fire.
Read next
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.